SPIE SA (SPIE.PA)

FR0012757854 - Common Stock

37.34  +0.5 (+1.36%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to SPIE. SPIE was compared to 44 industry peers in the Commercial Services & Supplies industry. While SPIE is still in line with the averages on profitability rating, there are concerns on its financial health. SPIE has a decent growth rate and is not valued too expensively.



6

1. Profitability

1.1 Basic Checks

SPIE had positive earnings in the past year.
In the past year SPIE had a positive cash flow from operations.
SPIE had positive earnings in each of the past 5 years.
SPIE had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

SPIE's Return On Assets of 2.61% is in line compared to the rest of the industry. SPIE outperforms 59.52% of its industry peers.
SPIE's Return On Equity of 12.22% is in line compared to the rest of the industry. SPIE outperforms 59.52% of its industry peers.
The Return On Invested Capital of SPIE (5.94%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for SPIE is below the industry average of 9.43%.
The 3 year average ROIC (5.25%) for SPIE is below the current ROIC(5.94%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.61%
ROE 12.22%
ROIC 5.94%
ROA(3y)2.09%
ROA(5y)1.75%
ROE(3y)10.11%
ROE(5y)8.83%
ROIC(3y)5.25%
ROIC(5y)4.73%

1.3 Margins

With a Profit Margin value of 2.73%, SPIE perfoms like the industry average, outperforming 54.76% of the companies in the same industry.
SPIE's Profit Margin has improved in the last couple of years.
SPIE has a Operating Margin (5.38%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of SPIE has grown nicely.
The Gross Margin of SPIE (42.82%) is comparable to the rest of the industry.
SPIE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.38%
PM (TTM) 2.73%
GM 42.82%
OM growth 3Y13.03%
OM growth 5Y5.09%
PM growth 3Y50.68%
PM growth 5Y14.88%
GM growth 3Y-1.1%
GM growth 5Y1.3%

3

2. Health

2.1 Basic Checks

SPIE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
SPIE has more shares outstanding than it did 1 year ago.
SPIE has more shares outstanding than it did 5 years ago.
The debt/assets ratio for SPIE has been reduced compared to a year ago.

2.2 Solvency

SPIE has an Altman-Z score of 1.68. This is a bad value and indicates that SPIE is not financially healthy and even has some risk of bankruptcy.
SPIE has a Altman-Z score (1.68) which is in line with its industry peers.
SPIE has a debt to FCF ratio of 3.82. This is a good value and a sign of high solvency as SPIE would need 3.82 years to pay back of all of its debts.
SPIE's Debt to FCF ratio of 3.82 is amongst the best of the industry. SPIE outperforms 80.95% of its industry peers.
A Debt/Equity ratio of 1.05 is on the high side and indicates that SPIE has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.05, SPIE is doing worse than 64.29% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.05
Debt/FCF 3.82
Altman-Z 1.68
ROIC/WACC0.94
WACC6.35%

2.3 Liquidity

SPIE has a Current Ratio of 0.92. This is a bad value and indicates that SPIE is not financially healthy enough and could expect problems in meeting its short term obligations.
SPIE has a Current ratio of 0.92. This is in the lower half of the industry: SPIE underperforms 71.43% of its industry peers.
SPIE has a Quick Ratio of 0.92. This is a bad value and indicates that SPIE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of SPIE (0.91) is worse than 61.90% of its industry peers.
Industry RankSector Rank
Current Ratio 0.92
Quick Ratio 0.91

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 55.46% over the past year.
The Earnings Per Share has been growing by 19.93% on average over the past years. This is quite good.
The Revenue has been growing slightly by 7.54% in the past year.
The Revenue has been growing slightly by 5.44% on average over the past years.
EPS 1Y (TTM)55.46%
EPS 3Y61.76%
EPS 5Y19.93%
EPS Q2Q%106.29%
Revenue 1Y (TTM)7.54%
Revenue growth 3Y9.43%
Revenue growth 5Y5.44%
Sales Q2Q%-43.18%

3.2 Future

The Earnings Per Share is expected to grow by 10.64% on average over the next years. This is quite good.
The Revenue is expected to grow by 5.18% on average over the next years.
EPS Next Y18.62%
EPS Next 2Y13.98%
EPS Next 3Y10.64%
EPS Next 5YN/A
Revenue Next Year12.2%
Revenue Next 2Y8.8%
Revenue Next 3Y7.65%
Revenue Next 5Y5.18%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 26.11, the valuation of SPIE can be described as expensive.
SPIE's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of SPIE to the average of the S&P500 Index (28.24), we can say SPIE is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 14.85, the valuation of SPIE can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SPIE indicates a somewhat cheap valuation: SPIE is cheaper than 64.29% of the companies listed in the same industry.
SPIE is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 19.93, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 26.11
Fwd PE 14.85

4.2 Price Multiples

SPIE's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SPIE indicates a somewhat cheap valuation: SPIE is cheaper than 73.81% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 9.56
EV/EBITDA 9.56

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of SPIE may justify a higher PE ratio.
PEG (NY)1.4
PEG (5Y)1.31
EPS Next 2Y13.98%
EPS Next 3Y10.64%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.30%, SPIE has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.92, SPIE pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.36, SPIE has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.3%

5.2 History

The dividend of SPIE is nicely growing with an annual growth rate of 6.15%!
Dividend Growth(5Y)6.15%
Div Incr Years3
Div Non Decr Years3

5.3 Sustainability

53.13% of the earnings are spent on dividend by SPIE. This is a bit on the high side, but may be sustainable.
The dividend of SPIE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP53.13%
EPS Next 2Y13.98%
EPS Next 3Y10.64%

SPIE SA

EPA:SPIE (5/24/2024, 7:00:00 PM)

37.34

+0.5 (+1.36%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap6.23B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 2.3%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 26.11
Fwd PE 14.85
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.4
PEG (5Y)1.31
Profitability
Industry RankSector Rank
ROA 2.61%
ROE 12.22%
ROCE
ROIC
ROICexc
ROICexgc
OM 5.38%
PM (TTM) 2.73%
GM 42.82%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 1.05
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.92
Quick Ratio 0.91
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)55.46%
EPS 3Y61.76%
EPS 5Y
EPS Q2Q%
EPS Next Y18.62%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)7.54%
Revenue growth 3Y9.43%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y